We use statistical-computational (e.g.,GWAS, multilayer network analysis) and biological (e.g., induced pluripotent stem cell or iPSC models) methods to study genetic risk variants and neurobiological mechanisms of psychosis symptoms, and clinically important outcomes such as treatment resistance.